Navigation Links
Study Reports Successful Cloning of Human Embryo Using Adult DNA
Date:1/17/2008

wing Somatic Cell Nuclear Transfer (SCNT) with Adult Fibroblasts," is available online at: http://stemcells.alphamedpress.org/cgi/reprint/2007-0252v1.

About AlphaMed Press

AlphaMed Press publishes the internationally renowned journals, "Stem Cells" and "The Oncologist." "Stem Cells," now in its 26th year, is the oldest and one of the world's top-tier peer-reviewed monthly journals in the fast-paced area of stem cells and regenerative medicine. "The Oncologist," in its 13th year, is a premier peer-reviewed monthly journal dedicated to physicians entrusted with the care of cancer patients. View AlphaMed Press journals at http://www.alphamedpress.org.

Contact: George Kendall: 919-680-0011, GKendall@alphamedpress.com.


'/>"/>
SOURCE AlphaMed Press
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Boehringer Ingelheim Announces Enrollment is Complete for the Largest Atrial Fibrillation Outcomes Trial - The RE-LY(TM) Study
2. Cogentus Pharmaceuticals Begins Clinical Study to Confirm the Full Antiplatelet Benefit of New Combination Medicine CGT-2168
3. Morria Biopharmaceuticals Plc Announces Preliminary Safety and Tolerability Results From Its Phase I Clinical Study of MRX-4 in Allergic Rhinitis Patients
4. Childrens Hospital Cancer Study Finds Adolescents and Young Adults Dont Get Same Access to Cutting-Edge Treatment as Younger Patients
5. Tolerx Achieves Milestone with Completion of Phase Ib Clinical Study of TRX1 in Cutaneous Lupus Erythematosus
6. Schering-Plough Reports Top-Line Results of the IDEAL Study
7. Positive Results from Phase IIa Study Pave Way for Phase IIb Trial of DG051 for the Prevention of Heart Attack
8. Knee Pain? An Exclusive Study Engineers Cartilage to Match Patients Own Tissue
9. Vion Pharmaceuticals Announces FDA Lift of Clinical Hold on Phase III Study of Cloretazine(R) (VNP40101M) and Cytarabine in Relapsed AML
10. Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder
11. Arena Pharmaceuticals Announces APD668 Initial Clinical Study Results Suggest Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control in Patients With Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)...  TransCelerate BioPharma Inc. ("TransCelerate") announces the ... Risk-Based Monitoring (RBM), " Evaluating Source Data ... Clinical Trials ," in the Drug Information ...  (TIRS) journal. Developed by TransCelerate,s 19 member ... examines the value of Source Data Verification ...
(Date:11/18/2014)... FT LAUDERDALE, Fla. , November 18, 2014 ... ), a leading solution provider of access control ... the company has joined the Green Rush Alliance ... solutions to  customers and businesses in the Cannabis ... products and services to medical marijuana dispensaries, retailers ...
(Date:11/18/2014)...  Zimmer Holdings, Inc. (NYSE and SIX: ZMH) ("Zimmer") ... Commission (the "EC") to extend the deadline for the ... a limited number of days in order to provide ... Deadline extensions are not uncommon in such in-depth investigations.  ... to facilitate their review of the pending transaction and ...
Breaking Medicine Technology:TransCelerate BioPharma Inc. Publishes Recommendation on Use of Source Data Verification in Risk-Based Monitoring, Releases Third Update on Initiative Progress 2TransCelerate BioPharma Inc. Publishes Recommendation on Use of Source Data Verification in Risk-Based Monitoring, Releases Third Update on Initiative Progress 3Profile Solutions, Inc Joins the Green Rush Alliance 2Profile Solutions, Inc Joins the Green Rush Alliance 3Zimmer Provides Update on the European Commission Review Process Relating to the Pending Merger with Biomet, Inc. 2Zimmer Provides Update on the European Commission Review Process Relating to the Pending Merger with Biomet, Inc. 3Zimmer Provides Update on the European Commission Review Process Relating to the Pending Merger with Biomet, Inc. 4Zimmer Provides Update on the European Commission Review Process Relating to the Pending Merger with Biomet, Inc. 5
... from a Phase III,clinical trial evaluating the efficacy ... the treatment of postmenopausal osteoporosis were,presented at the ... Annual Meeting. In the non-inferiority study comparing risedronate ... [Actonel(R) (risedronate sodium,tablets)] increases in bone mineral density ...
... Medical,Technologies, Inc. (Nasdaq: RMTI ), a ... specialty pharmaceuticals focused on the end-,stage-renal-disease market ... in its Phase IIb dose-ranging study for ... drug. The Phase IIb dose-ranging study ...
Cached Medicine Technology:New Phase III Data Presented for Once Monthly Dosing Regimen of Risedronate to Treat Postmenopausal Osteoporosis 2New Phase III Data Presented for Once Monthly Dosing Regimen of Risedronate to Treat Postmenopausal Osteoporosis 3New Phase III Data Presented for Once Monthly Dosing Regimen of Risedronate to Treat Postmenopausal Osteoporosis 4New Phase III Data Presented for Once Monthly Dosing Regimen of Risedronate to Treat Postmenopausal Osteoporosis 5New Phase III Data Presented for Once Monthly Dosing Regimen of Risedronate to Treat Postmenopausal Osteoporosis 6Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study 2Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study 3Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study 4
(Date:11/21/2014)... Thompson HealthDay Reporter THURSDAY, ... into the wall of a still-beating heart has the potential ... according to a new study. Heart patients who received ... able to walk hundreds of feet farther during a six-minute ... chief of the cardiovascular division at Washington University School of ...
(Date:11/21/2014)... 2014 (HealthDay News) -- Kidney donation is one of ... And now a new study finds that former donors who ... from policies that give them priority on the transplant waiting ... the 16,900 kidney transplants that took place in the United ... study researchers. At the time of donation, most ...
(Date:11/18/2014)... Hawthorne, CA (PRWEB) November 18, 2014 ... implants more affordable for patients. Nearly 70 percent of Americans ... those over the age of 74, 25 percent are missing ... tooth replacement options are available, but only one offers a ... teeth. , This special includes a complimentary consultation that ...
(Date:11/18/2014)... TUESDAY, Nov. 18, 2014 (HealthDay News) -- Routine screening ... who have no symptoms but are at high risk ... Researchers found the screenings do not help prevent ... the hospital for unstable angina (chest pain that occurs ... Properly controlling diabetes is still the best way to ...
(Date:11/18/2014)... 18, 2014 Global Partnership ... the telehealth platform to bring quality healthcare to ... passion, GPT created Global Partnership for TeleHealth Missions ... existing telehealth network. GPTM focuses specifically on ... and disaster relief organizations. , Michael ...
Breaking Medicine News(10 mins):Health News:Gel Implant Might Help Fight Heart Failure 2Health News:Gel Implant Might Help Fight Heart Failure 3Health News:Study Supports Giving Kidney Donors Priority When They Need a Kidney 2Health News:Hawthorne Dentist, Dr. Yashari, is Now Making Dental Implants More Affordable for Patients 2Health News:Study Finds No Added Benefit From Routine Heart Scans for Diabetics 2Health News:Study Finds No Added Benefit From Routine Heart Scans for Diabetics 3Health News:Global Partnership for TeleHealth (GPT) is Focused on Using the telehealth Platform to Bring Quality Healthcare to Populations in Need Worldwide 2
... the NHS on April 1. Dentists in England and Wales ... April 1st. Several Cumbrian practices have // already opted out. ... when leaving the NHS. ,But now due to ... days notice. The North Cumbria Primary Care Trusts (PCTs) cannot ...
... Uttar Pradesh rural doctors are angry at the village heads, ... medics. The doctors have threatened to go on an indefinite ... health secretary last week directed district chief medical officers to ... community health centres with the help of village chiefs or ...
... boy battling life with life support should be kept alive, ... High Court. // This is a landmark judgement, especially, since ... support, to allow him to die, rather than prolong a ... ,The Judge’s ruling disallowed the NHS trust to sweep aside ...
... administered a potentially deadly radiation overdose .Lisa Norris, is trying ... treatment. // She has re-joined school and will be celebrating ... Girvan in Ayrshire, in a case of human error, was ... Centre in Glasgow. She was being treated for brain tumor. ...
... XR drug for attention deficit hyperactivity disorder (ADHD) needs to ... the US FDA regulators. // ,It has ... about the side effects of the drug such as hallucinations ... with no identifiable risk factors. The FDA had prepared a ...
... Amanda Walmsley who worked in developing a vaccine against the ... flu in tomatoes. // ,The tomato bird flu ... tomatoes which are the storehouse of vaccines would be fed ... a very simple procedure the fruits are harvested, freeze-dried and ...
Cached Medicine News:
... The HARMONY Cardiology Module incorporates an ... with Open Systems Technology mandated by ... protocols. Allowing for easy access to ... communications, HARMONY provides new efficiency with ...
... VitalWorks' practice management systems have brought cutting-edge ... bases in the world. Today, Intuition PM ... in a friendly, intuitive manner. Automate patient ... expedite in-office patient processing through wireless hand-held ...
... Total Practice Partner is a ... manage all of the mission-critical functions ... Partner includes Patient Records, one of ... systems, Appointment Scheduler, a sophisticated multi-clinic ...
... EpicCare is the most successful EMR ... proven scalability facilitate improvements that deliver ... service improvements from our clients abound, ... increasing patient satisfaction. They have realized ...
Medicine Products: